Intuitive Surgical (ISRG) Depreciation & Amortization (CF) (2009 - 2026)
Intuitive Surgical (ISRG) posted quarterly Depreciation & Amortization (CF) of $192.3 million for Q2 2026, up 26.43% year-over-year from $152.1 million in Q2 2025, and up 7.49% quarter-over-quarter from $178.9 million in Q1 2026.
Intuitive Surgical (ISRG) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Intuitive Surgical's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $192.3 million for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 26.43% year-over-year to $192.3 million; the TTM figure through Jun 2026 stood at $696.3 million (up 32.91% YoY), while the FY2025 annual figure was $614.7 million, up 38.04% from the prior year.
- Depreciation & Amortization (CF) for Q2 2026 stood at $192.3 million, up from $178.9 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $192.3 million in Q2 2026, with the low at $77.7 million in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $109.8 million (2024), against an average of $120.6 million.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) gained 2.96% in 2024, then soared 42.42% in 2025.
- Intuitive Surgical's Depreciation & Amortization (CF) stood at $98.6 million in 2022, then gained by 19.78% to $118.1 million in 2023, then increased by 2.96% to $121.6 million in 2024, then jumped by 38.49% to $168.4 million in 2025, then advanced by 14.19% to $192.3 million in 2026.
- Business Quant data shows ISRG's Depreciation & Amortization (CF) at $192.3 million in Q2 2026, $178.9 million in Q1 2026, and $168.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 40.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 192.30 Mn |
| Jun 30, 2026 | 192.30 Mn |
| Mar 31, 2026 | 178.90 Mn |
| Mar 31, 2026 | 178.90 Mn |
| Dec 31, 2025 | 168.40 Mn |
| Dec 31, 2025 | 168.40 Mn |
| Sep 30, 2025 | 156.70 Mn |
| Sep 30, 2025 | 156.70 Mn |
| Jun 30, 2025 | 152.10 Mn |
| Jun 30, 2025 | 152.10 Mn |
| Mar 31, 2025 | 137.50 Mn |
| Mar 31, 2025 | 137.50 Mn |
| Dec 31, 2024 | 121.60 Mn |
| Dec 31, 2024 | 121.60 Mn |
| Sep 30, 2024 | 112.70 Mn |
| Sep 30, 2024 | 112.70 Mn |
| Jun 30, 2024 | 106.80 Mn |
| Jun 30, 2024 | 106.80 Mn |
| Mar 31, 2024 | 104.20 Mn |
| Mar 31, 2024 | 104.20 Mn |